<DOC>
	<DOC>NCT02994368</DOC>
	<brief_summary>The purpose of this study is to understand the rate of progression of all stages of choroideremia using a variety of assessments performed in the clinic including visual field measures, specialized photography of the eye and participant-reported visual problems</brief_summary>
	<brief_title>"Natural History" Study of Choroideremia</brief_title>
	<detailed_description />
	<mesh_term>Choroideremia</mesh_term>
	<criteria>Healthy individuals with choroideremia (20/200 or better vision) willing to participate in an observational study and meeting the eligibility criteria. 1. Prior therapy with an AAV vectorbased treatment 2. Preexisting eye conditions that would: (1) preclude future planned treatment in a therapeutic intent clinical trial (i.e. intravitreal injection), (2) interfere with the interpretation of study endpoints, and/ or put patient at risk for surgical complications 3. Complicating systemic diseases that would preclude future enrollment in a therapeutic intent clinical trial 4. Any other condition that would not allow the potential subject to complete followup examinations during the course of the study and, in the opinion of the investigator, makes the potential subject unsuitable for the study.</criteria>
	<gender>Male</gender>
	<minimum_age>14 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>retinal degeneration</keyword>
	<keyword>eye</keyword>
	<keyword>REP-1 gene</keyword>
</DOC>